Phenolics removal from transgenic Lemna minor extracts expressing mAb and impact on mAb production cost
- 12 November 2010
- journal article
- research article
- Published by Wiley in Biotechnology Progress
- Vol. 27 (2) , 410-418
Abstract
Transgenic Lemna minor has been used successfully to produce several biotherapeutic proteins. For plant‐produced mAbs specifically, the cost of protein A capture step is critical as the economic benefits of plant production systems could be erased if the downstream processing ends up being expensive. To avoid potential modification of mAb or fouling of expensive protein A resins, a rapid and efficient removal of phenolics from plant extracts is desirable. We identified major phenolics in Lemna extracts and evaluated their removal by adsorption to PVPP, XAD‐4, IRA‐402, and Q‐Sepharose. Forms of apigenin, ferulic acid, and vitexin comprised ∼75% of the total phenolics. Screening of the resins with pure ferulic acid and vitexin indicated that PVPP would not be efficient for phenolics removal. Analysis of the breakthrough fractions of phenolics adsorption to XAD‐4, IRA‐402, and Q‐Sepharose showed differences in adsorption with pH and in the type of phenolics adsorbed. Superior dynamic binding capacities (DBC) were observed at pH 4.5 than at 7.5. To evaluate the cost impact of a phenolics removal step before protein A chromatography, a mAb purification process was simulated using SuperPro Designer 7.0. The economic analysis indicated that addition of a phenolics adsorption step would increase mAb production cost only 20% by using IRA‐402 compared to 35% for XAD‐4 resin. The cost of the adsorption step is offset by increasing the lifespan of protein A resin and a reduction of overall mAb production cost could be achieved by using a phenolics removal step. © 2011 American Institute of Chemical Engineers Biotechnol. Prog., 2011Keywords
This publication has 25 references indexed in Scilit:
- Purification of Antibodies From Transgenic Plants2008
- Considerations for extraction of monoclonal antibodies targeted to different subcellular compartments in transgenic tobacco plantsPlant Biotechnology Journal, 2008
- Is the Drought Over for Pharming?2008
- Very Large Scale Monoclonal Antibody Purification: The Case for Conventional Unit OperationsBiotechnology Progress, 2007
- Combined adsorption and ion exchange equilibrium of phenol on Amberlite IRA-420Chemical Engineering Journal, 2006
- Challenges in biotechnology production—generic processes and process optimization for monoclonal antibodiesChemical Engineering and Processing - Process Intensification, 2005
- Downstream processing of recombinant proteins from transgenic feedstockCurrent Opinion in Biotechnology, 2004
- The production of recombinant pharmaceutical proteins in plantsNature Reviews Genetics, 2003
- Adsorption of phenolic compounds on Amberlite XAD-4 and its acetylated derivative MX-4Reactive and Functional Polymers, 2001
- Optimum conditions for bonding of plant phenols to insoluble polyvinylpyrrolidonePhytochemistry, 1968